The simple reduction of platelet counts, also a known mechanism of circulating TPO regulation, seems less likely, as it would not explain the differences in HCC and mCRC patients as well as in the extent of resection that we observed in our investigation. The gene discussed is TPO; the disease is hepatocellular carcinoma.